Healthcare Services

Intravenous Solutions Market Growth Forecast With Analysis Of Industry Progress Through 2030

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Intravenous Solutions Market By 2030?

The market for intravenous solutions has demonstrated substantial growth in recent years. It is anticipated to increase from $14.91 billion in 2025 to $16.05 billion in 2026, driven by a compound annual growth rate (CAGR) of 7.6%. The historical growth can be attributed to several factors, including an increase in hospital admissions and surgical procedures, the extensive use of IV fluids for dehydration management, a rising prevalence of chronic diseases, the established critical role of IV therapy, and the expanding utilization of electrolyte and glucose solutions.

The market for intravenous solutions is projected to experience substantial expansion over the coming years. This market is anticipated to reach $21.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the projection period include the spread of home healthcare and outpatient infusion offerings, an expanding elderly demographic in need of nutritional assistance, the growing embrace of individualized nutrition treatments, progress in sterile packaging innovations, and an escalating need for extended parenteral nutrition. Key developments expected within the forecast timeframe encompass an increasing requirement for intravenous hydration across acute and chronic care settings, broader application of parenteral nutrition in intensive and elderly care, a rising inclination towards pre-mixed IV solution formulations, the proliferation of home-based IV treatment and infusion provisions, and an intensified emphasis on maintaining sterility and safety in the creation of IV solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What Important Drivers Are Powering The Intravenous Solutions Market Growth?

The escalating incidence of cancer is anticipated to drive the expansion of the Intravenous Solutions Market in the coming years. Cancer encompasses a range of diseases marked by unregulated cellular proliferation and the capacity to invade nearby tissues and spread throughout the body. Intravenous solutions play a crucial role in cancer therapy, facilitating the administration of chemotherapy drugs and ensuring proper hydration during treatment. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that new cancer cases would surpass 35 million by 2050, indicating a 77% increase over the estimated 20 million cases in 2022. Consequently, the increasing prevalence of cancer is a primary catalyst for the growth observed in the Intravenous Solutions Market.

How Is The Intravenous Solutions Market Distributed Across Key Segments?

The intravenous solutions market covered in this report is segmented –

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition

2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients

3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution

4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:

1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions

2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Which Trends Are Influencing The Direction Of The Intravenous Solutions Market?

Leading companies within the intravenous solutions market are focusing on the development of innovative syringes, such as pre-filled and ready-to-administer types, to gain a competitive advantage. These pre-filled and ready-to-administer syringes come preloaded with medication and are designed for immediate use, removing the necessity for manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, introduced KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. These syringes are crafted from a transparent, durable polymer material, thereby eliminating risks associated with glass syringes. Being pre-filled and ready to administer, they contribute to saving time and decreasing medication errors. Rocuronium bromide injection is intended exclusively for intravenous use. It offers several critical features, including RFID-enabled integration with KitCheck, which represents the latest kit and tray management technology, intuitive labeling, and a color-coded plunger rod to facilitate rapid identification.

Which Firms Are Competing In The Intravenous Solutions Market?

Major companies operating in the intravenous solutions market are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Access The Complete Intravenous Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

What Is The Largest Regional Market In The Intravenous Solutions Market?

North America was the largest region in the intravenous solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Intravenous Solutions Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=13465&type=smp

Browse Through More Reports Similar to the Global Intravenous Solutions Market 2026, By The Business Research Company

Intravenous Solutions Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

Empty Intravenous Iv Bags Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/empty-intravenous-iv-bags-global-market-report

Peripheral Iv Catheters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795